Filing Details
- Accession Number:
- 0001209191-23-023062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-04 19:59:34
- Reporting Period:
- 2023-04-03
- Accepted Time:
- 2023-04-04 19:59:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1247681 | Bryan V Lawlis | C/O Biomarin Pharmaceutical Inc. 770 Lindaro Street San Rafael CA 94901 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-04-03 | 8,500 | $67.81 | 37,450 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-04-03 | 8,500 | $97.09 | 28,950 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy Common Stock) | Disposition | 2023-04-03 | 8,500 | $0.00 | 8,500 | $67.81 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-11-15 | 2023-05-14 | No | 4 | M | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on August 29, 2022.
- Reflects the number of options outstanding after the transactions from this specific stock option grant.